Myeloid dendritic cells from human cutaneous squamous cell carcinoma are poor stimulators of T-cell proliferation. - Wikidata - awgldk - TriplyDB

Myeloid dendritic cells from human cutaneous squamous cell carcinoma are poor stimulators of T-cell proliferation.

Myeloid dendritic cells from human cutaneous squamous cell carcinoma are poor stimulators of T-cell proliferation.

http://www.wikidata.org/entity/Q33757576

about

Functional Specialization of Skin Dendritic Cell Subsets in Regulating T Cell Responses Understanding dendritic cells and their role in cutaneous carcinoma and cancer immunotherapy Metabolic control of dendritic cell activation and function: recent advances and clinical implications S100A8/A9 stimulates keratinocyte proliferation in the development of squamous cell carcinoma of the skin via the receptor for advanced glycation-end products Th17 cells and activated dendritic cells are increased in vitiligo lesions The interplay between surfaces and soluble factors define the immunologic and angiogenic properties of myeloid dendritic cells.Comparative immune phenotypic analysis of cutaneous Squamous Cell Carcinoma and Intraepidermal Carcinoma in immune-competent individuals: proportional representation of CD8+ T-cells but not FoxP3+ Regulatory T-cells is associated with disease stage.Role of immune-regulatory cells in skin pathology.Nitric oxide controls an inflammatory-like Ly6C(hi)PDCA1+ DC subset that regulates Th1 immune responses Increased Tc22 and Treg/CD8 ratio contribute to aggressive growth of transplant associated squamous cell carcinoma.An animal explant model for the study of human cutaneous squamous cell carcinoma.Roles of the immune system in skin cancer.Tumor-associated macrophages in the cutaneous SCC microenvironment are heterogeneously activated Skin cancer in transplant recipients, out of the woods. Scientific retreat of the ITSCC and SCOPE.Cyclosporine A immunosuppression drives catastrophic squamous cell carcinoma through IL-22.Interleukin 6 regulates psoriasiform inflammation-associated thrombosis.Retrospective chart review of skin cancer presence in the wide excisions Liposomes targeting tumour stromal cells.The immunoregulatory mechanisms of carcinoma for its survival and development Interleukin-22 and Cyclosporine in Aggressive Cutaneous Squamous Cell Carcinoma.Plasmacytoid dendritic cells in skin lesions of classic Kaposi's sarcoma.Langerhans cells from human cutaneous squamous cell carcinoma induce strong type 1 immunity Toll-like receptors: role in dermatological disease.Langerhans Cells: Sensing the Environment in Health and Disease.Hedgehog/Gli1 signal pathway facilitates proliferation, invasion, and migration of cutaneous SCC through regulating VEGF.Alterations of the Human Skin N- and O-Glycome in Basal Cell Carcinoma and Squamous Cell Carcinoma.Peritumoral dermis of squamous cell carcinomas in renal transplant recipients contains less CD11c+ myeloid dendritic cells and FoxP3+ T cells compared to immunocompetent controls.

P2860

Q26777948-AEBE34DA-9378-4F01-8CDD-474AE8A7D48E Q27004702-BA90AD64-028E-4DEB-9E18-6A86220242E7 Q28385947-ED408BB8-21DA-4095-994D-7A5057F6A43F Q28545019-386FC6FB-A7D2-4362-8C7F-06D0381C9C48 Q33889471-EA9499AB-9184-434A-AECE-CD2752D637C9 Q33924531-F45E5160-5D4B-496C-8A02-0EBD2328F2E6 Q34396026-D8D403C0-C080-49F7-B544-E7C9F3572D67 Q34417553-89FE5168-61A9-492F-AC92-E66B8F03E53B Q34580296-CB0FD3D8-862F-4668-9C30-B8143B3A8603 Q34717034-2B06511B-0DEB-464B-82EC-9022C51BF0C3 Q35014599-33A9412D-9EB3-4236-A98C-50FDA166B7ED Q35403714-D07831A8-CA3A-4656-B2E7-8C3A57B7F839 Q35906771-0D65744F-01AB-4880-A29C-C876DF7D839B Q37053236-E071F90B-07F6-4A82-B5B9-7F2F52142840 Q37277272-DDF6BE80-BE44-4738-A96E-008EA2DEA05E Q37469175-24E9488E-BA81-47DF-8D37-922EFA5AF2CF Q37640178-2123A4C1-6D11-4471-AEE5-C15A62C3DBF1 Q37799613-BF401D68-BFCC-4D14-AA7A-45024C27110C Q37831426-63BA73F2-9CF2-4C5D-AA5D-79B91F4E98AD Q39021344-7498F95B-DBA1-4DE2-8D9C-10E71C8D1735 Q40627365-140BFCC1-6E28-4C6E-800E-B492D53AE6FB Q42147428-3F8B064A-DFC4-4C1E-9406-84536CA93233 Q42431181-C85A6219-70E8-4830-9EBB-3EA870F1F3CA Q49024330-9FED2612-56DF-41DA-BE11-941CDAF5C92F Q51381877-4477748E-66E5-4A25-831F-E4D8050882E4 Q52331518-0EB8F3F6-95FE-4D16-8F3E-277690613CB3 Q53556283-5672405F-95E3-47E6-AC0A-784A81CAC2D9

P2860

Myeloid dendritic cells from human cutaneous squamous cell carcinoma are poor stimulators of T-cell proliferation.

http://www.wikidata.org/entity/Q33757576

description

2009 nî lūn-bûn

@nan

2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Myeloid dendritic cells from h ...... ators of T-cell proliferation.

@ast

Myeloid dendritic cells from h ...... ators of T-cell proliferation.

@en

type

label

Myeloid dendritic cells from h ...... ators of T-cell proliferation.

@ast

Myeloid dendritic cells from h ...... ators of T-cell proliferation.

@en

prefLabel

Myeloid dendritic cells from h ...... ators of T-cell proliferation.

@ast

Myeloid dendritic cells from h ...... ators of T-cell proliferation.

@en

P1433

Q33757576-7D92F0DB-7482-4B0C-A389-109967EDDAB1

P1476

Q33757576-D47139BD-11E3-4187-8209-FCF691AA5165

P2093

Q33757576-1091A67A-0CC4-470E-B8A8-914ED6E75713

Q33757576-10EF2CA0-BD43-4B3D-8BE2-A9EE92462C5C

Q33757576-1BC11D5E-D9A7-4271-B013-7FCBA8B132C5

Q33757576-1F25C029-1BFE-447D-8482-4CA8E0710CF2

Q33757576-29AD5F57-DBB6-4E0B-8F4D-03746E58A6C5

Q33757576-29BB6617-1C16-460B-B4EA-F40489C759DC

Q33757576-529462F4-3746-498F-8381-1CD2ECA61C3E

Q33757576-85703796-E500-42B0-A2D9-E78973C867B7

Q33757576-AE260921-99B1-4EF6-84E2-AB560E426D1E

Q33757576-C4A5E525-1AD7-4935-A12E-54FF49DB529F

P2860

Q33757576-021BD568-C760-4A47-98CB-F94412EC56CD

Q33757576-036A68D8-A7E3-4961-A2C6-720A0F738F23

Q33757576-09DE9D11-A78A-42D4-9705-8B65B5BAFA75

Q33757576-0B3BF3CE-9489-4960-B847-8DB0FF11ED8A

Q33757576-13BA4DE4-DAC6-4883-BACE-9EB5E33A71E6

Q33757576-24130C0D-8B5D-461B-B0CF-C06D2A2B5D7B

Q33757576-29C9F39E-FD88-452D-A320-39FFF4790E80

Q33757576-2E6E9E5F-AB67-4C11-ADBC-35B9644B7055

Q33757576-3A76E975-F6EB-44C1-B18E-21ED22AFA9DB

Q33757576-44977E4E-9EDE-4D6D-83CC-21447785A8D1

P2888

Q33757576-ECAC0371-B41A-48BC-8A90-E265FBD830A8

P304

Q33757576-E979B0D3-2FAB-4F11-B3C0-F7599404E64F

P31

Q33757576-873CE9CC-690F-47A3-A60D-42D00EE8755A

P356

Q33757576-77576DE8-FDFF-441D-A2C6-98F8501D0A2F

P407

Q33757576-40E0E98B-FFCB-4012-90BF-CA14E75B30E9

P433

Q33757576-3727EE5B-3949-4FFE-894F-9345264739A6

P478

Q33757576-FDC0A662-A5F2-4F97-8F4E-B7B09F67187A

P50

Q33757576-F45A3119-CD96-46FD-91E1-68A2A72B7AA5

P577

Q33757576-8A493019-B414-4936-854A-1B17BF17B4E5

P5875

Q33757576-C4E1D342-AB52-4287-8325-704524962EEA

P6179

Q33757576-778E38C4-DAF0-46CA-86ED-4409BCACA84C

P698

Q33757576-84CCA970-15F9-4F48-9DBF-87C5670A3BBD

P932

Q33757576-7EF4A719-2813-4565-84E4-4A389EA445FE

P356

P1433

Journal of Investigative Dermatology

P1476

Myeloid dendritic cells from h ...... ators of T-cell proliferation.

@en

P2093

Alexander Pitts-Kiefer

http://www.w3.org/2001/XMLSchema#string

Dariush Moussai

http://www.w3.org/2001/XMLSchema#string

Emma Guttman-Yassky

http://www.w3.org/2001/XMLSchema#string

Helen Kaporis

http://www.w3.org/2001/XMLSchema#string

James G Krueger

http://www.w3.org/2001/XMLSchema#string

John A Carucci

http://www.w3.org/2001/XMLSchema#string

Judilyn Fuentes-Duculan

http://www.w3.org/2001/XMLSchema#string

Katherine C Pierson

http://www.w3.org/2001/XMLSchema#string

Linda Fan

http://www.w3.org/2001/XMLSchema#string

Lisa C Zaba

http://www.w3.org/2001/XMLSchema#string

P2860

The nature of the principal type 1 interferon-producing cells in human blood

Myeloid progenitor cells mediate immune suppression in patients with head and neck cancers.

Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells.

T cells from the tumor microenvironment of patients with progressive myeloma can generate strong, tumor-specific cytolytic responses to autologous, tumor-loaded dendritic cells.

Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a)

VEGF as a mediator of tumor-associated immunodeficiency.

IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis

L-arginine metabolism in myeloid cells controls T-lymphocyte functions.

Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells.

Distribution of dendritic cell subtypes in primary oral squamous cell carcinoma is inconsistent with a functional response.

P2888

P304

2451-2462

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/JID.2009.96

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

129

http://www.w3.org/2001/XMLSchema#string

P50

Michelle A Lowes

P577

2009-04-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24350804

http://www.w3.org/2001/XMLSchema#string

P6179

1019130850

http://www.w3.org/2001/XMLSchema#string

P698

19387481

http://www.w3.org/2001/XMLSchema#string

P932

2846605

http://www.w3.org/2001/XMLSchema#string